A Human-Safe Drug Reduces Multiple Signs of Alzheimer's in Mice
Researchers have identified a drug, KCL-286, that shows promise in reducing signs of Alzheimer's disease in mouse models. Because the drug has already passed initial human safety trials for other conditions, it could potentially move to clinical testing for Alzheimer's much faster than typical new treatments.
Why it matters
Repurposing existing, safety-tested drugs could significantly accelerate the development of treatments for neurodegenerative diseases.
Add ScienceAlert on Google Sticky protein clumps clog up brain cells in Alzheimer's disease. (Sciepro/Science Photo Library/Getty Images) Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of weakness.
The article reports on scientific findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in